Minerva Neurosciences, Inc. (NERV)
2.42
+0.12
(+5.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.415
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences EPS Diluted (TTM) : -28.87 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.87 |
| March 31, 2026 | -29.16 |
| December 31, 2025 | -26.80 |
| September 30, 2025 | -1.853 |
| June 30, 2025 | 1.484 |
| March 31, 2025 | 0.8264 |
| December 31, 2024 | 0.1901 |
| September 30, 2024 | -0.4375 |
| June 30, 2024 | -4.445 |
| March 31, 2024 | -4.481 |
| December 31, 2023 | -4.654 |
| September 30, 2023 | -4.722 |
| June 30, 2023 | -4.981 |
| March 31, 2023 | -5.490 |
| December 31, 2022 | -6.013 |
| September 30, 2022 | -8.743 |
| June 30, 2022 | -9.175 |
| March 31, 2022 | -9.525 |
| December 31, 2021 | -9.345 |
| September 30, 2021 | -6.727 |
| June 30, 2021 | -6.552 |
| March 31, 2021 | 1.296 |
| December 31, 2020 | 0.4638 |
| September 30, 2020 | -4.296 |
| June 30, 2020 | -5.610 |
| Date | Value |
|---|---|
| March 31, 2020 | -14.03 |
| December 31, 2019 | -14.80 |
| September 30, 2019 | -11.39 |
| June 30, 2019 | -11.00 |
| March 31, 2019 | -11.03 |
| December 31, 2018 | -10.35 |
| September 30, 2018 | -7.597 |
| June 30, 2018 | -7.357 |
| March 31, 2018 | -6.930 |
| December 31, 2017 | -6.767 |
| September 30, 2017 | -8.96 |
| June 30, 2017 | -8.64 |
| March 31, 2017 | -7.92 |
| December 31, 2016 | -7.84 |
| September 30, 2016 | -8.40 |
| June 30, 2016 | -8.40 |
| March 31, 2016 | -9.12 |
| December 31, 2015 | -9.28 |
| September 30, 2015 | -9.76 |
| June 30, 2015 | -20.08 |
| March 31, 2015 | -38.32 |
| December 31, 2014 | -35.84 |
| September 30, 2014 | -35.92 |
| June 30, 2014 | -24.64 |
| March 31, 2014 | -5.041 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Heron Therapeutics, Inc. | -0.19 |
| Tonix Pharmaceuticals Holding Corp. | -12.93 |
| Karyopharm Therapeutics, Inc. | -13.08 |
| Corbus Pharmaceuticals Holdings, Inc. | -6.177 |
| Ocugen, Inc. | -0.1993 |